About Oncodesign Services
Oncodesign Services is a company based in Dijon (France) founded in 1995. Oncodesign Services has raised $23.96 million across 1 funding round from investors including Eurazeo. Oncodesign Services has completed 1 acquisition, including ZoBio. Oncodesign Services offers products and services including Medicinal Chemistry Services, In Vivo Pharmacology, and DMPK Services. Oncodesign Services operates in a competitive market with competitors including BioTelemetry, Calyx, Molecular NeuroImaging, Imaging Endpoints and CROmed, among others.
- Headquarter Dijon, France
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Oncodesign Services
Oncodesign Services offers a comprehensive portfolio of products and services, including Medicinal Chemistry Services, In Vivo Pharmacology, and DMPK Services.
Designs and synthesizes compounds for therapeutic development
Conducts studies on drug efficacy in animal models
Evaluates drug metabolism and pharmacokinetics
People of Oncodesign Services
Unlock access to complete
Funding Insights of Oncodesign Services
Oncodesign Services has successfully raised a total of $23.96M through 1 strategic funding round. The most recent funding activity was a Private Equity Round of $23.96 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Oncodesign Services
Oncodesign Services has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Eurazeo.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and debt investments are managed across multiple sectors.
|
Locked | Locked | Locked |
Investor details for Oncodesign Services
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Oncodesign Services
Oncodesign Services has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include ZoBio.
Investment portfolio details for Oncodesign Services
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of fragment-based drug discovery services
|
Locked | Locked | 2004 | Locked |
Complete acquisition details for Oncodesign Services
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Oncodesign Services
Detailed financials for Oncodesign Services
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Oncodesign Services Comparisons
Peer comparison for Oncodesign Services
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Oncodesign Services
Oncodesign Services operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioTelemetry, Calyx, Molecular NeuroImaging, Imaging Endpoints and CROmed, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Wireless products for monitoring health parameters are offered.
|
|
| Locked | Locked | Locked |
CRO providing imaging services for clinical development
|
|
| Locked | Locked | Locked |
Company offering specialized imaging services for neurodegenerative and neuropsychiatric disorders
|
|
| Locked | Locked | Locked |
Offers medical imaging expertise for oncology research and clinical trials globally.
|
|
| Locked | Locked | Locked |
Specialized imaging services for preclinical and clinical research are provided.
|
Detailed competitors of Oncodesign Services
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Oncodesign Services
Complete news archive for Oncodesign Services
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Oncodesign Services
Oncodesign Services was founded in 1995 and raised its 1st funding round 29 years after it was founded.
Oncodesign Services is headquartered in Dijon, France. It is registered at Dijon, Bourgogne-franche-comte, France.
Oncodesign Services is a funded company, having raised a total of $23.96M across 1 funding round to date.
Oncodesign Services was founded in 1995 in Dijon, France, as a contract research organization specializing in oncology. Drug discovery processes, bioanalysis techniques, and preclinical studies are conducted to support pharmaceutical development. Operations are centered on therapeutic innovation in cancer treatments, with services extending to global clients in the biopharmaceutical sector. Expertise is applied across early-stage research phases to ensure regulatory compliance and scientific accuracy.
Oncodesign Services's top competitors include BioTelemetry, Calyx and Molecular NeuroImaging.
Oncodesign Services offers Medicinal Chemistry Services, In Vivo Pharmacology, and DMPK Services.
Oncodesign Services has made 1 acquisition, including ZoBio.
Oncodesign Services has 1 investor. Key investors include Eurazeo.